Yorkville Ives initiates Zoom stock coverage with outperform rating

Yorkville Ives initiated coverage of Zoom with an Outperform rating and a $120 price target, versus a cited share price of $94.68, framing the company’s AI tools and broader collaboration platform as an opportunity to expand enterprise workflow spending. Zoom reported Q2 results above consensus for revenue, billings and non-GAAP EPS, though its non-GAAP operating margin missed estimates; analysts also cited accelerating enterprise growth alongside weaker online performance and churn challenges.

Analysis

The investable question is whether Zoom can turn meeting context into paid workflows—not whether it can launch more AI features. Its distribution may lower customer-acquisition friction, but Salesforce, ServiceNow and Atlassian have stronger claims to owning customer, service and project workflows. Zoom is more likely to win as an embedded interface than displace those systems of record; integrations can expand utility while leaving monetization and retention with incumbents. That limits the near-term read-through to CRM, NOW and TEAM, but raises the risk of feature bundling and pricing pressure for narrower collaboration tools.

The bullish case is not yet established by product breadth or company-wide gross margin: verify paid AI attach, expansion within enterprise accounts, retention, and incremental operating costs. AI features included in existing plans could improve engagement without lifting revenue, while inference and support costs could dilute operating leverage. Recent enterprise strength is encouraging, but weaker online performance and a below-estimate operating margin argue against treating the platform narrative as proven.

Days: the analyst upgrade can support sentiment, but competing ratings and no new operating data make chasing the move unattractive. Over 1–3 months, watch earnings disclosures for AI monetization and enterprise bookings. Over 6–18 months, success could support a higher-quality recurring-revenue narrative; failure to show paid adoption leaves Zoom exposed to slower growth and multiple compression. Falsify the constructive view if enterprise growth or retention weakens, operating margin continues to miss, or AI adoption fails to convert into incremental revenue. The broader market/yield backdrop may dominate near-term multiples; it does not validate Zoom’s product thesis.

Key Decisions for Investors

• No immediate momentum trade. Treat the $120 target as an analyst view, not a catalyst; avoid chasing around the cited $94.68 price without evidence of paid AI conversion.
• Put ZM on an earnings watchlist: require measurable disclosure on paid AI adoption or expansion, enterprise retention/bookings, and operating-margin trajectory before adding. If these improve together, consider a staged long; reduce or pass if growth is driven mainly by existing customers using unmonetized features.
• Monitor CRM, NOW and TEAM for evidence of bundling, pricing concessions, or slower seat expansion. Do not short them solely on Zoom’s product announcements; their workflow and system-of-record positions make displacement a higher bar.